How much does Pralsetinib cost per month?

Pralsetinib (Pralsetinib), trade name Gavreto, is a drug approved for RET mutation-positive medullary thyroid cancer (MTC) and RET fusion-positive differentiated thyroid cancer (DTC), which is ineffective in radioactive iodine (RAI) treatment. Pratinib is a tyrosine kinase inhibitor that contains the active substance pralsetinib. It is an oral capsule preparation after it is launched.

Platinib is a cancer drug that can be used to treat adults with advanced non-small cell lung cancer (called RET fusion-positive NSCLC) caused by changes in a gene called RET who are not receiving treatment with RET inhibitors. Patients are advised to take 400 milligrams of Platinib daily with a glass of water on an empty stomach. The drug is only available with a prescription. The common specifications of platinib are 100mg*120 tablets. Patients need to take about one box a month. If discomfort occurs after taking it, the doctor may adjust or stop the dosage.

It is understood that the original drug Platinib has been launched in China, but it has not yet entered the scope of medical insurance. The price of each box of 100mg*120 tablets may be around 60,000 yuan, which is expensive. The price of the European version of 100mg*60 capsules sold overseas may be around 40,000 yuan per box, and the price of the American version may be around 150,000 yuan per box (prices may fluctuate due to exchange rates). The ingredients of domestic and foreign original drugs are basically the same. There is currently no generic version of Platinib available on the market. Please consult your medical consultant for specific prices and drug details.